Midodrine is not being taken off the market. The brand-name version, ProAmatine, was discontinued by its manufacturer, but the drug itself remains widely available as a generic. If you’ve seen headlines or rumors about midodrine being pulled, the confusion likely traces back to a complicated regulatory history that made it seem like the FDA was about to yank the drug entirely. That never happened.
What Actually Happened With ProAmatine
Midodrine was originally approved in 1996 under the FDA’s accelerated approval pathway, a process reserved for drugs that treat serious or life-threatening conditions and show enough promise to reach patients quickly. Under this pathway, a drug can be approved based on a “surrogate endpoint,” meaning a measurable effect (like raising blood pressure when standing) that is reasonably likely to predict a real clinical benefit, even if that ultimate benefit hasn’t been fully proven yet.
The catch: the manufacturer is required to conduct follow-up studies after approval to confirm the drug actually delivers meaningful benefits to patients. For midodrine, those confirmatory studies were never completed on time. By 2010, the FDA publicly proposed withdrawing its approval because the required post-marketing evidence still hadn’t materialized. That proposal generated significant media coverage and alarm among patients who relied on the drug daily.
The FDA ultimately did not withdraw midodrine. Confirmatory data was eventually provided, and the drug kept its approval. Separately, the original manufacturer, Shire, stopped selling the brand-name ProAmatine. The FDA formally determined in 2019 that ProAmatine “was not withdrawn from sale for reasons of safety or effectiveness.” That distinction matters because it cleared the way for generic versions to continue being approved and sold without any cloud over the drug’s safety record.
Midodrine Is Widely Available as a Generic
Far from being scarce, midodrine hydrochloride tablets are currently produced by roughly 20 different generic manufacturers, including Mylan, Apotex, Aurobindo, and Zydus, among others. It’s available in 2.5 mg, 5 mg, and 10 mg tablets. If your pharmacy carries it, you’re getting one of these generic versions, and they contain the same active ingredient as the original brand-name product.
How Midodrine Works
Midodrine treats orthostatic hypotension, the condition where your blood pressure drops significantly when you stand up, causing dizziness, lightheadedness, or fainting. The drug itself is actually a prodrug, meaning your body converts it into an active form called desglymidodrine after you swallow it. That active form tightens blood vessels in your arteries and veins, which raises blood pressure enough to reduce symptoms when you’re upright.
One notable feature: the active form doesn’t cross into the brain easily, so it doesn’t cause the kind of central nervous system side effects (drowsiness, mood changes) that some blood pressure medications do. It also doesn’t stimulate the heart to beat faster, which makes it a relatively targeted treatment.
The Key Risk to Know About
Midodrine’s most serious concern is that it can raise blood pressure too much when you’re lying down. In clinical trials, about 13% of patients taking 10 mg developed systolic blood pressure readings above 200 mmHg while lying flat. At higher doses (20 mg), that figure rose to 45%. These elevated pressures often lasted six hours or more.
This is why the drug carries strong warnings about supine hypertension, and why patients are typically advised not to lie flat for several hours after taking a dose. People whose resting blood pressure already runs above 180/110 mmHg were excluded from the original clinical trials entirely, and the drug is not recommended for anyone with persistent, excessive high blood pressure while lying down. If you take midodrine, your doctor will likely monitor your blood pressure in both positions.
Other Treatment Options for Orthostatic Hypotension
Midodrine isn’t the only medication used for orthostatic hypotension. Droxidopa (Northera) works through a different mechanism, converting to norepinephrine in the body to raise blood pressure. Fludrocortisone helps the body retain salt and fluid, which increases blood volume. Pyridostigmine (Mestinon) is sometimes used as well, particularly in patients who can’t tolerate blood pressure spikes while lying down. Each option has a different side effect profile, so the choice often depends on what other conditions you have and how your body responds.
Non-drug strategies also play a significant role: wearing compression stockings, increasing salt and fluid intake, standing up slowly, and elevating the head of the bed at night. For many people, treatment involves a combination of lifestyle changes and medication.